Miglustat, sold under the brand name Zavesca among others, is a medication used to treat type I Gaucher disease and Pompe disease. From Wikipedia
Zevra Therapeutics' Miplyffa, in combination with miglustat, is now approved to treat neurological symptoms in NPC patients aged 2 and older.
